Caliper Reiterates '09 Revenue Guidance | GenomeWeb

NEW YORK (GenomeWeb News) – Caliper Life Sciences yesterday reiterated its expectation of organic 2009 revenue growth of between 4 percent and 7 percent and total revenues of between $125 million and $129 million.

The Hopkinton, Mass.-based firm provided the update during a Customer and Investor Open House at its headquarters, which also was webcast. Company officials said during the event that second-quarter revenues from research and imaging products were tracking ahead of expectations, offsetting weakness in the company's service business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.